tiprankstipranks
Advertisement
Advertisement

ERAS Stock Latest News

H.C. Wainwright sees pressure for Erasca shares pending safety visibility
The FlyH.C. Wainwright sees pressure for Erasca shares pending safety visibility
1d ago
ERAS
Midday Fly By: OpenAI said to miss targets, Coca-Cola reports Q1 beat
PremiumThe Fly
Midday Fly By: OpenAI said to miss targets, Coca-Cola reports Q1 beat
1d ago
GM
KO
Erasca falls -52.6%
PremiumThe Fly
Erasca falls -52.6%
1d ago
ERAS
Erasca falls -46.0%
PremiumThe Fly
Erasca falls -46.0%
1d ago
ERAS
Unusually active option classes on open April 28th
PremiumThe Fly
Unusually active option classes on open April 28th
1d ago
KO
ASX
Erasca falls after disclosing patient died after withdrawing from trial
PremiumThe FlyErasca falls after disclosing patient died after withdrawing from trial
1d ago
ERAS
Erasca price target raised to $9 from $2 at BofA
Premium
The Fly
Erasca price target raised to $9 from $2 at BofA
1d ago
ERAS
RVMD
Analyst Maintains Buy on ERAS-0015’s Promising Early Data, Keeps Price Target Unchanged at $20
Premium
Ratings
Analyst Maintains Buy on ERAS-0015’s Promising Early Data, Keeps Price Target Unchanged at $20
1d ago
ERAS
Closing Bell Movers: Sanmina jumps over 10% on earnings beat
PremiumThe Fly
Closing Bell Movers: Sanmina jumps over 10% on earnings beat
2d ago
CR
DG
Erasca Reports Encouraging Phase 1 Data for ERAS-0015
PremiumCompany Announcements
Erasca Reports Encouraging Phase 1 Data for ERAS-0015
2d ago
8K
ERAS
Erasca announces preliminary dose escalation data for ERAS-0015
PremiumThe Fly
Erasca announces preliminary dose escalation data for ERAS-0015
2d ago
ERAS
Erasca believes Revolution infringement claims ‘without merit,’ says Stifel
PremiumThe Fly
Erasca believes Revolution infringement claims ‘without merit,’ says Stifel
2d ago
ERAS
RVMD
Erasca falls -9.9%
PremiumThe FlyErasca falls -9.9%
2d ago
ERAS
Erasca sinks after Revolution Medicines alleges patent infringement
Premium
The Fly
Erasca sinks after Revolution Medicines alleges patent infringement
2d ago
ERAS
RVMD
Erasca Highlights ERAS-0015 Phase 1 Data Update
Premium
Company Announcements
Erasca Highlights ERAS-0015 Phase 1 Data Update
2d ago
8K
ERAS
Erasca price target raised to $30 from $20 at Stifel
PremiumThe Fly
Erasca price target raised to $30 from $20 at Stifel
2d ago
ERAS
Erasca Tightens Timeline for ERAS-0015 Phase 1 Data
PremiumCompany Announcements
Erasca Tightens Timeline for ERAS-0015 Phase 1 Data
8d ago
8K
ERAS
ERAS: Promising RAS-Mutant Oncology Pipeline and China Partnership Support Buy Rating
PremiumRatings
ERAS: Promising RAS-Mutant Oncology Pipeline and China Partnership Support Buy Rating
16d ago
ERAS
Bar remains unchanged for Erasca after Revolution’s ‘clear win,’ says Jefferies
PremiumThe Fly
Bar remains unchanged for Erasca after Revolution’s ‘clear win,’ says Jefferies
16d ago
ERAS
RVMD
Erasca drops 9% to $15.54 after Revolution pancreatic cancer data
PremiumThe FlyErasca drops 9% to $15.54 after Revolution pancreatic cancer data
16d ago
ERAS
RVMD
Erasca falls -7.9%
Premium
The Fly
Erasca falls -7.9%
16d ago
ERAS
Erasca falls -10.6%
Premium
The Fly
Erasca falls -10.6%
16d ago
ERAS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >